In addition, the data from an online database indicated that miR-320a could bind to the 3′-UTR of E2F1, which is a well-known transcriptional activator that has been determined to be extensive involved in tumour progression in such cancers as bladder cancer 42 breast cancer 43, and lung cancer 44. Here, E2F1 is linked to breast cancer.